White House drug pricing plan faces skepticism as experts question feasibility of Trump's executive order to align US prices ...

President Donald Trump on Monday made a sweeping promise to bring down drug prices and stop pharma companies from taking ...

Roche said its $50 billion promise to expand its manufacturing footprint in the US has the potential to be 'reassessed.' ...

Stylus Medicine, a startup founded by Patrick Hsu, has raised $85 million to develop a suite of technologies that it believes ...

Vir Biotech's hepatitis B therapy shows 4% cure rate with doublet (tobevibart/elebsiran) and 10% with triplet therapy, below ...

Pres­i­dent Don­ald Trump said he’ll take ex­ec­u­tive ac­tion to have the US pay no more than oth­er coun­tries for drugs, a ...

New data shows Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy in weight loss, with 65% vs 40% of patients achieving ...

FDA clears Ensoma's trial of in vivo blood stem cell editing therapy for X-linked chronic granulomatous disease, following China's Yoltech earlier this year.

Lonza said on Friday it does not expect any 'material financial impact' from current and potential pharma-specific tariffs.

Lan­theus fi­nal­ly came clean about the fate of its ex­per­i­men­tal ra­dio­phar­ma­ceu­ti­cal for prostate can­cer, ...

Insilico Medicine files third HKEX IPO attempt, as biotech develops rentosertib for IPF and other drugs with AI-driven ...

After working off $20 million in seed funding for about four years, HAYA Therapeutics tapped the funding well and came back ...